Insiders

Maze Therapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol: MAZE
Industry: Biological Products, (No Diagnostic Substances)
Location: 171 Oyster Point Boulevard, Suite 300, San Francisco, CA

There are no Buy or Sell transactions made by insiders since 3/5/2024

Maze Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Jason V. Coloma	Chief Executive Officer, Director				Jan 30, 2025
Richard H. Scheller	Director				Jan 30, 2025
Catherine A. Sohn	Director				Jan 30, 2025
Atul Dandekar	Csbo				Jan 30, 2025
Daniel K. Spiegelman	Director				Jan 30, 2025
Amy Bachrodt	SVP, Finance				Jan 30, 2025
Jeffrey K. Tong	Director				Jan 30, 2025
Harold Bernstein	President, R&D & CMO				Jan 30, 2025
ARCH Venture Partners X, LLC	10%+ Owner				Jan 30, 2025
Courtney Phillips	GC and Corp. Secretary				Jan 30, 2025
Third Rock Ventures IV, L.P.	10%+ Owner				Feb 3, 2025
Nancy C. Andrews	Director				Jan 30, 2025
James Brush	Director				Jan 30, 2025
Alan Colowick	Director				Jan 30, 2025
Neil Exter	Director				Jan 30, 2025
Charles J. Homcy	Director				Feb 3, 2025
Sekar Kathiresan	Director				Jan 30, 2025
Jonathan E. Lim	Director				Feb 3, 2025

Showing 1 to 18 of 18 entries

Recent Insider Transactions by Companies or Individuals for Maze Therapeutics, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.